Division of Pediatrics
Dean A. Lee has not added Biography.
If you are Dean A. Lee and would like to personalize this page please email our Author Liaison for assistance.
Activated peripheral T lymphocytes undergo apoptosis when cultured with monocytes activated by HLA class II ligation.
Cellular immunology Oct, 2003 | Pubmed ID: 14698144
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.
Immunity Jan, 2004 | Pubmed ID: 14738769
Granulocytic sarcoma presenting as pneumonia in a child with t(8;21) acute myelogenous leukemia: diagnosis by fluorescent in situ hybridization.
Journal of pediatric hematology/oncology Jul, 2004 | Pubmed ID: 15218417
Rotavirus vaccines.
The New England journal of medicine Apr, 2006 | Pubmed ID: 16625014
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.
Pediatric blood & cancer Mar, 2008 | Pubmed ID: 17243127
C/EBPbeta suppression by interruption of CUGBP1 resulting from a complex rearrangement of MLL.
Cancer genetics and cytogenetics Sep, 2007 | Pubmed ID: 17854664
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
Human gene therapy Apr, 2010 | Pubmed ID: 19905893
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.
Cancer research May, 2010 | Pubmed ID: 20424114
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.
Biomedical microdevices Oct, 2010 | Pubmed ID: 20574820
Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapy.
Methods in molecular biology (Clifton, N.J.) , 2010 | Pubmed ID: 20686960
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.
Cancer research May, 2011 | Pubmed ID: 21558388
Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies.
Human gene therapy Jan, 2012 | Pubmed ID: 22107246
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells.
PloS one , 2012 | Pubmed ID: 22279576
NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation.
Immunotherapy Feb, 2012 | Pubmed ID: 22329587
Natural killer cells in malignant hematology: A primer for the non-immunologist.
Blood reviews Mar, 2017 | Pubmed ID: 27665023
The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3.
Scientific reports Mar, 2017 | Pubmed ID: 28338101
Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines.
Frontiers in immunology , 2017 | Pubmed ID: 28428785
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation.
Molecular immunology Aug, 2017 | Pubmed ID: 28644973
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Breast cancer research : BCR Jul, 2017 | Pubmed ID: 28668076
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.
Blood 10, 2017 | Pubmed ID: 28835441
Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: A Multicenter Cohort Study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Feb, 2018 | Pubmed ID: 29128552
Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) Feb/Mar, 2018 | Pubmed ID: 29189387
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.
Journal for immunotherapy of cancer Dec, 2017 | Pubmed ID: 29254507
Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells.
Cancer immunology, immunotherapy : CII Apr, 2018 | Pubmed ID: 29299659
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
PloS one , 2018 | Pubmed ID: 29342200
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Nature communications Apr, 2018 | Pubmed ID: 29674644
Copyright © 2024 MyJoVE Corporation. 판권 소유